Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences PharmaAQ

PharmaAQ Agenda

Co-Located Conference Agendas

Advances in Food and Beverage Analysis | PharmaAQ | 

Print Agenda

Thursday, 11 October 2018






Introduction of Resource Persons and Memento Presentation


Business Networking Session


Group Photograph


Coffee Break and Networking in Exhibition Area

Plenary Talk


Nondestructive Pharmaceutical Analysis and Visualization
Saranjit Singh, Professor/Head, NIPER Mohali, India

This talk will be focused on nondestructive pharmaceutical analysis, process analytical technologies (PAT), and pharmaceutical visualization. The major techniques involved include Attenuated Total Reflectance (ATR); Near Infrared (NIR), FT-Raman, Terahertz, X-Ray, Quadrupole Resonance (QR) Spectroscopy, Frequency Modulation Spectroscopy (FMS), TOF-SIMS, etc

Scientific Session I - Management in Analytical R&D


Analytical Procedure Lifecycle - USP <1220>
Mrunal Jaywant, Senior Director, USP India Private Limited, India

USP has proposed new general chapter “<1220> The Analytical Procedure Lifecycle” to address the entire procedure lifecycle and to define concepts. Dr Jaywant will explain and discuss about this new general chapter <1220> which will provide guidance to facilitate the management of post-approval changes in a more predictable and efficient manner across the product life cycle and it will promote innovation and continual improvement, and strengthen quality assurance and reliable supply of a product.


Analytical Method Transfers – Best Practices and Challenges
B M Rao, Vice President & Head – ASAT & CQC, Dr Reddy's Laboratories, India

A successful AMT requires accurate communication between the transferring and receiving laboratories and a clear plan with defined roles and responsibilities. But the most important takeaway is to never treat an AMT as a checkbox routine. Differences in instrumentation, techniques, procedures and even interpretations of an analytical procedure can lead to preventable AMT failures. Dr Rao will extensively cover some of the best practices to be adopted during AMTs and how to address the key challenges. 

Scientific Session II - Analytical Method Development & Validation
Session SponsorsSession Sponsor


Analytical Method Development and Validation
Yogita Kodgule, Director - Chief Analytical & Regulatory Affairs, IQGEN-X Pharma, India


Daicel Chiral TechnologiesElemental Impurities by ICP-MS
P Radha Krishnanand, Associate Director-Business Development, Daicel Chiral Technologies


Advanced Chemistry Development IncA New Approach towards Chromatographic Method Development for Pharma Industry
K K Bhagchandani, Director, Advanced Chemistry Development Inc


Lunch Break and Networking in Exhibition Area

Scientific Session III - Analytical Considerations During Drug Development
Session SponsorsSession Sponsor


Handling Sample Preparation Criticality during Drug Development and Beyond
Manohar Sonanis, Ex- Vice President and Head, Lyrus Life Sciences Pvt Ltd, India


Anant Pharmaceuticals Pvt LtdAnalytical Considerations during Drug Development
Ajit Godbole, Managing Director, Anant Pharmaceuticals Pvt Ltd


Coffee Break and Networking in Exhibition Area

Workshop on Data Analytics
Session SponsorsSession Sponsor


Workshop: This Workshop focuses on analysing different types of from various sources (People, Instruments like NIR, NMR, Mass Spec, Wet Chemistry, sensors, Process) and combining them to predict final quality, safety and efficacy of produced goods. For details, follow link


David Wang, Principal Data Scientist, Sartorius Stedim Data Analytics, Singapore


Vaibhav Patil, Sr. Data Scientist, Sartorius Stedim Data Analytics, India


End of Day One of Conference

Friday, 12 October 2018

Scientific Session IV - Analytical Considerations for Stability of Pharmaceutical and Biopharmaceutical


Stability Studies Challenges and their Solutions of Various Formulations
Harvinder Singh, Head - Analytical R&D, IPCA Laboratories Ltd, India


Kinetic Modeling of Accelerated Stability Studies for Predicting Drug Product Stability
Gautam Samanta, Vice President - Quality by Design and Process Scale-up, Cipla Ltd, India


Role of Advanced Analytics -Mass Spectrometry in Monoclonal Antibody (mAb) Stability Assessment
Ravi Krovidi, Lead Investigator - Biopharmaceutical Development, Syngene International Ltd, India


Coffee Break and Networking in Exhibition Area

Scientific Session V - Recent Trends in Bioanalytical Method


Bioanalytical Method Development, Validation, and Clinical Sample Analysis
Manoj Shukla, Vice President Operations, Panexcell Clinical Labs Pvt Ltd, India


Green Bioanalytical Lab - A Vision of Bioanalytical Entrepreneur
Manish S Yadav, CEO, ETHIXINN Consulting & Research Solutions, India

Scientific Session VI - Leveraging Analytical QbD for Method Development


QbD Approach for Analytical Method Development (Analytical QbD)
Bhaskar Kolte, Associate Director -ARD, Perrigo Laboratories India Pvt. Ltd., India


Optimization of a Liquid Chromatography Method for the Analysis of Related Substances using Design of Experiments Integrated with the Steepest Ascent Method and Monte Carlo Simulation
Trupti Tol, Associate Director, Cipla Ltd, India

An analytical method for the determination of related substances (RS) was optimised using quality by design (QbD) approach. The DoE study uncovered hidden peaks and unknown criticalities, which would eventually lead to method and product failure.  Since this was a sensitive case of method development it was treated accordingly, and techniques such as method of steepest ascent were adopted to attain the optimum condition. Finally, the method robustness was proved and fortified through capability analysis and Monte Carlo simulations and this is going to be a focus of Ms Tol’s talk.


Interactive Session: This is a specially designed informal open session in which the delegates will get an opportunity to interact with the experts/speakers in an informal open session.


Lunch Break and Networking in Exhibition Area

Scientific Session VII - PAT Applications in Quality Control


Continuous Manufacturing and Real-time Release Testing
Rameshwar Nalawade, Head - Quality and Analytical Development, STEERLife India Pvt Ltd, India

Continuous manufacturing can offer significant quality and cost advantages over batch manufacturing of pharmaceutical drugs and drug products. Real time release testing is a best system for continuous manufacturing. Dr Nalawade in his talk will focus on continuous manufacturing through real time release testing with respect to Process Quality by design and Analytical quality by design in pharmaceutical development.  


Implementation of Process Analytical Tools (PAT)-Raman and NIR in Pharmaceutical Development
Mallikarjun Narayanam, Senior Research Investigator, Biocon Bristol Myers-Squibb R&D Center, India


Coffee Break and Networking in Exhibition Area

Scientific Session VIII - Current Challenges in Quality Management


Data Reliability - A Growing Concern in Pharmaceutical Industry
Arun Mendiratta, Associate Vice President, Aurobindo Pharma, India


Advanced Aseptic Behavior and Challenges
Anil Fokmare, Head- Quality (Formulation-Unit 3), Alembic Pharmaceuticals Ltd., India


Conference Feedback


Closing Remarks and Vote of Thanks


End of the Conference

Add to Calendar ▼2018-10-11 00:00:002018-10-12 00:00:00Europe/LondonPharmaAQPharmaAQ in